IMNM
Price
$8.77
Change
-$0.02 (-0.23%)
Updated
Jun 27 closing price
Capitalization
763.1M
44 days until earnings call
KYTX
Price
$3.28
Change
-$0.19 (-5.48%)
Updated
Jun 27 closing price
Capitalization
141.76M
49 days until earnings call
Interact to see
Advertisement

IMNM vs KYTX

Header iconIMNM vs KYTX Comparison
Open Charts IMNM vs KYTXBanner chart's image
Immunome
Price$8.77
Change-$0.02 (-0.23%)
Volume$1.07M
Capitalization763.1M
Kyverna Therapeutics
Price$3.28
Change-$0.19 (-5.48%)
Volume$3.72M
Capitalization141.76M
IMNM vs KYTX Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. KYTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and KYTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IMNM: $8.77 vs. KYTX: $3.28)
Brand notoriety: IMNM and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 120% vs. KYTX: 845%
Market capitalization -- IMNM: $763.1M vs. KYTX: $141.76M
IMNM [@Biotechnology] is valued at $763.1M. KYTX’s [@Biotechnology] market capitalization is $141.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while KYTX’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 4 bearish.
  • KYTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than KYTX.

Price Growth

IMNM (@Biotechnology) experienced а +0.40% price change this week, while KYTX (@Biotechnology) price change was +6.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

KYTX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($763M) has a higher market cap than KYTX($142M). KYTX YTD gains are higher at: -12.299 vs. IMNM (-17.420). KYTX has higher annual earnings (EBITDA): -143.14M vs. IMNM (-175.18M). IMNM has more cash in the bank: 317M vs. KYTX (243M). IMNM has less debt than KYTX: IMNM (4.77M) vs KYTX (6.94M). IMNM has higher revenues than KYTX: IMNM (10.9M) vs KYTX (0).
IMNMKYTXIMNM / KYTX
Capitalization763M142M537%
EBITDA-175.18M-143.14M122%
Gain YTD-17.420-12.299142%
P/E RatioN/AN/A-
Revenue10.9M0-
Total Cash317M243M130%
Total Debt4.77M6.94M69%
TECHNICAL ANALYSIS
Technical Analysis
IMNMKYTX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KUBTF10.85N/A
N/A
Kubota Corp.
SPTJF0.16N/A
N/A
Sinopec Shanghai Petrochemical Co. Ltd.
CLVSF19.28N/A
N/A
Cellavision AB
WSTRF0.58-0.03
-5.14%
Western Uranium & Vanadium Corp.
MNTR0.04-0.01
-14.89%
Mentor Capital, Inc.

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.23%
IDYA - IMNM
61%
Loosely correlated
-4.13%
ARWR - IMNM
56%
Loosely correlated
+0.06%
BEAM - IMNM
55%
Loosely correlated
-1.98%
RXRX - IMNM
55%
Loosely correlated
-6.85%
SYRE - IMNM
54%
Loosely correlated
-4.99%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IPSC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-5.48%
IPSC - KYTX
52%
Loosely correlated
-5.74%
CRSP - KYTX
47%
Loosely correlated
N/A
IMNM - KYTX
46%
Loosely correlated
-0.23%
RXRX - KYTX
45%
Loosely correlated
-6.85%
TRDA - KYTX
45%
Loosely correlated
-1.57%
More